Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systemic Bioactivity of Inhaled Nebulized RNS60

NCT02490865 is registered in ClinicalTrials.gov with Revalesio Corporation as lead sponsor.

NCT NCT02490865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02490865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systemic Bioactivity of Inhaled Nebulized RNS60
Lead sponsor
Revalesio Corporation
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2015
Completion date
August 31, 2015
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic bioactivity of nebulized rns60